Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analgesic effect of endomorphin-1.

Z H Li1, L D Shan, X H Jiang

  • 1Department of Physiology, School of Medicine, Showa University, Tokyo 142, Japan.

Acta Pharmacologica Sinica
|December 26, 2001
PubMed
Summary

Endomorphin-1 (EM-1) demonstrates significant pain relief in animal models, acting faster and more effectively when administered centrally. Its analgesic effects are mediated by central mu-opioid receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Dyspnea, pulmonary mosaic sign and pulmonary hypertension].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2026
Same author

[Experimental study on the role of TRPM2 in regulating osteoblast differentiation through mitophagy in periodontitis].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Same author

[Characteristics of left ventricular structure and function and their influencing factors in elderly individuals with primary aldosteronism].

Zhonghua yi xue za zhi·2025
Same author

[Sonodynamic therapy promotes luminal gain in carotid and femoral atherosclerotic plaques: a single-center prospective clinical study].

Zhonghua xin xue guan bing za zhi·2025
Same author

[Inhibition of NLRP3 inflammasome by sonodynamic therapy mediates CACNA1C upregulation to reduce atrial fibrillation susceptibility].

Zhonghua xin xue guan bing za zhi·2025
Same author

[Clinical characteristics of juvenile dermatomyositis in anti-nuclear matrix protein 2 antibody-positive patients and risk factors for severity: a national multicenter retrospective study].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2025

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Research

Background:

  • Opioid peptides play a crucial role in pain modulation.
  • Endomorphin-1 (EM-1) is an endogenous opioid peptide with potential analgesic properties.

Purpose of the Study:

  • To investigate the analgesic efficacy of endomorphin-1 (EM-1).
  • To compare central versus peripheral administration routes of EM-1.
  • To elucidate the receptor mechanisms underlying EM-1's analgesic effects.

Main Methods:

  • Animal models (rats and mice) were used to assess pain responses.
  • Tests included tail-stimulation vocalization, writhing test, adjuvant arthritis, and neuropathic pain.
  • EM-1 was administered via intraperitoneal (ip), intracerebroventricular (icv), and intrathecal (it) routes.

Related Experiment Videos

  • Reversal studies utilized naloxone and cyprodime (mu-opioid antagonist).

    • Main Results:

    • EM-1 produced dose-dependent analgesia in various pain models.
    • Central administration (icv, it) of EM-1 yielded more rapid and potent effects than peripheral (ip) administration.
    • The analgesic effects were antagonized by naloxone and cyprodime, indicating mu-opioid receptor involvement.
    • Repeated EM-1 administration led to the development of tolerance.

    Conclusions:

    • EM-1 exhibits significant analgesic properties.
    • The analgesic action of EM-1 is primarily mediated through central mu-opioid receptors.
    • EM-1 represents a potential therapeutic agent for pain management.